PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$27.13
+0.44%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.51
- Revenue estimate
- $340.6M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.36
- EPS estimate
- $0.33
- Revenue actual
- $350.5M
- Revenue estimate
- $349.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +11.3%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $35
- PT range
- $30 – $40
- Analysts
- 8
6 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.33 | $0.36 | Beat 7.53% | $350.5M |
| May 7, 2026 | $0.26 | $0.29 | Beat 13.28% | $328.5M |
| Nov 6, 2025 | $0.39 | $0.45 | Beat 15.38% | $313.3M |
| Aug 7, 2025 | $0.44 | $0.48 | Beat 9.09% | $332.9M |
| May 8, 2025 | $0.45 | $0.48 | Beat 6.67% | $324.0M |
| Feb 27, 2025 | $0.37 | $0.42 | Beat 13.51% | $298.4M |
| May 9, 2024 | $0.14 | $0.39 | Beat 178.57% | $278.1M |
| Feb 27, 2024 | $0.11 | $0.32 | Beat 190.91% | $269.9M |
| Aug 3, 2023 | $0.10 | $0.15 | Beat 50.00% | $279.4M |
| Feb 27, 2023 | $0.01 | $0.03 | Beat 157.07% | $214.3M |
| Nov 3, 2022 | $0.05 | $0.13 | Beat 160.00% | $205.4M |
| Aug 4, 2022 | $0.05 | $0.09 | Beat 80.00% | $195.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026